US Patent 12060428 Anti-IL36R antibodies
Patent 12060428 was granted and assigned to Regeneron Pharmaceuticals on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+521 characters)
US Patent 12060428 Anti-IL36R antibodies
Article
Patent abstract
The present invention provides antibodies and antigen-binding fragments (e.g., human antibodies) that bind specifically to human Interleukin-36 receptor (IL36R). Methods for treating or preventing diseases mediated by IL36R (e.g., skin or colon inflammatory conditions such as palmo-plantar pustular psoriasis, palmoplantar pustulosis, generalized pustular psoriasis, ulcerative colitis or IBD) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elena Garnova0
Jeanette Fairhurst0
Sokol Haxhinasto0
William Olson0
Date of Patent
August 13, 2024
0Patent Application Number
175903190
Date Filed
February 1, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12060428 Anti-IL36R antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
